Potential use of drug carried-liposomes for cancer therapy via direct intratumoral injection

Ande Bao, William T Phillips, Beth Goins, Xiangpeng Zheng, Sarmad Sabour, Mohan Natarajan, F. Ross Woolley, Cristina Zavaleta, Randal A Otto

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Liposomes have recognized advantages as nano-particle drug carriers for tumor therapy. In this study, the pharmacokinetics and distribution of intratumorally administered liposomes were investigated as drug carriers for treating solid tumors via direct intratumoral administration. 99mTc-liposomes were administered intratumorally to nude rats bearing human head and neck squamous cell carcinoma xenografts. Planar gamma camera images were analyzed to evaluate the local retention of the intratumorally administered liposomes. Co-registered pinhole micro-single photon emission computed tomography (SPECT)/computed tomography (CT) images were acquired of the whole animal as well as the dissected tumors to determine intratumoral distribution of the 99mTc-liposomes. For 99mTc-liposomes, there was an initial retention of 47.4 ± 11.0% (n = 4) in tumors and surrounding tissues. At 20 h, 39.2 ± 10.6% (n = 4) of 99mTc-activity still remained in the tumor. In contrast, only 18.7 ± 3.3% (n = 3) of the intratumoral 99mTc-activity remained for unencapsulated 99mTc-complex at 20 h. Pinhole micro-SPECT images demonstrated that 99mTc-liposomes also have a superior intratumoral 99mTc-activity diffusion compared with unencapsulated 99mTc-complex. Higher intratumoral retention of 99mTc-liposomes accompanied by an improved intratumoral diffusion suggests that intratumorally administered liposomal drugs are potentially promising agents for solid tumor local therapy.

Original languageEnglish (US)
Pages (from-to)162-169
Number of pages8
JournalInternational Journal of Pharmaceutics
Volume316
Issue number1-2
DOIs
StatePublished - Jun 19 2006

Fingerprint

Liposomes
Injections
Pharmaceutical Preparations
Neoplasms
Drug Carriers
Therapeutics
Nude Rats
Gamma Cameras
Single-Photon Emission-Computed Tomography
Heterografts
Pharmacokinetics

Keywords

  • Drug delivery
  • Intratumoral administration
  • Liposomes
  • Micro-CT
  • Micro-SPECT
  • Nuclear imaging

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Potential use of drug carried-liposomes for cancer therapy via direct intratumoral injection. / Bao, Ande; Phillips, William T; Goins, Beth; Zheng, Xiangpeng; Sabour, Sarmad; Natarajan, Mohan; Ross Woolley, F.; Zavaleta, Cristina; Otto, Randal A.

In: International Journal of Pharmaceutics, Vol. 316, No. 1-2, 19.06.2006, p. 162-169.

Research output: Contribution to journalArticle

Bao, A, Phillips, WT, Goins, B, Zheng, X, Sabour, S, Natarajan, M, Ross Woolley, F, Zavaleta, C & Otto, RA 2006, 'Potential use of drug carried-liposomes for cancer therapy via direct intratumoral injection', International Journal of Pharmaceutics, vol. 316, no. 1-2, pp. 162-169. https://doi.org/10.1016/j.ijpharm.2006.02.039
Bao, Ande ; Phillips, William T ; Goins, Beth ; Zheng, Xiangpeng ; Sabour, Sarmad ; Natarajan, Mohan ; Ross Woolley, F. ; Zavaleta, Cristina ; Otto, Randal A. / Potential use of drug carried-liposomes for cancer therapy via direct intratumoral injection. In: International Journal of Pharmaceutics. 2006 ; Vol. 316, No. 1-2. pp. 162-169.
@article{f6c53fc889a940689173716ad6396eec,
title = "Potential use of drug carried-liposomes for cancer therapy via direct intratumoral injection",
abstract = "Liposomes have recognized advantages as nano-particle drug carriers for tumor therapy. In this study, the pharmacokinetics and distribution of intratumorally administered liposomes were investigated as drug carriers for treating solid tumors via direct intratumoral administration. 99mTc-liposomes were administered intratumorally to nude rats bearing human head and neck squamous cell carcinoma xenografts. Planar gamma camera images were analyzed to evaluate the local retention of the intratumorally administered liposomes. Co-registered pinhole micro-single photon emission computed tomography (SPECT)/computed tomography (CT) images were acquired of the whole animal as well as the dissected tumors to determine intratumoral distribution of the 99mTc-liposomes. For 99mTc-liposomes, there was an initial retention of 47.4 ± 11.0{\%} (n = 4) in tumors and surrounding tissues. At 20 h, 39.2 ± 10.6{\%} (n = 4) of 99mTc-activity still remained in the tumor. In contrast, only 18.7 ± 3.3{\%} (n = 3) of the intratumoral 99mTc-activity remained for unencapsulated 99mTc-complex at 20 h. Pinhole micro-SPECT images demonstrated that 99mTc-liposomes also have a superior intratumoral 99mTc-activity diffusion compared with unencapsulated 99mTc-complex. Higher intratumoral retention of 99mTc-liposomes accompanied by an improved intratumoral diffusion suggests that intratumorally administered liposomal drugs are potentially promising agents for solid tumor local therapy.",
keywords = "Drug delivery, Intratumoral administration, Liposomes, Micro-CT, Micro-SPECT, Nuclear imaging",
author = "Ande Bao and Phillips, {William T} and Beth Goins and Xiangpeng Zheng and Sarmad Sabour and Mohan Natarajan and {Ross Woolley}, F. and Cristina Zavaleta and Otto, {Randal A}",
year = "2006",
month = "6",
day = "19",
doi = "10.1016/j.ijpharm.2006.02.039",
language = "English (US)",
volume = "316",
pages = "162--169",
journal = "International Journal of Pharmaceutics",
issn = "0378-5173",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Potential use of drug carried-liposomes for cancer therapy via direct intratumoral injection

AU - Bao, Ande

AU - Phillips, William T

AU - Goins, Beth

AU - Zheng, Xiangpeng

AU - Sabour, Sarmad

AU - Natarajan, Mohan

AU - Ross Woolley, F.

AU - Zavaleta, Cristina

AU - Otto, Randal A

PY - 2006/6/19

Y1 - 2006/6/19

N2 - Liposomes have recognized advantages as nano-particle drug carriers for tumor therapy. In this study, the pharmacokinetics and distribution of intratumorally administered liposomes were investigated as drug carriers for treating solid tumors via direct intratumoral administration. 99mTc-liposomes were administered intratumorally to nude rats bearing human head and neck squamous cell carcinoma xenografts. Planar gamma camera images were analyzed to evaluate the local retention of the intratumorally administered liposomes. Co-registered pinhole micro-single photon emission computed tomography (SPECT)/computed tomography (CT) images were acquired of the whole animal as well as the dissected tumors to determine intratumoral distribution of the 99mTc-liposomes. For 99mTc-liposomes, there was an initial retention of 47.4 ± 11.0% (n = 4) in tumors and surrounding tissues. At 20 h, 39.2 ± 10.6% (n = 4) of 99mTc-activity still remained in the tumor. In contrast, only 18.7 ± 3.3% (n = 3) of the intratumoral 99mTc-activity remained for unencapsulated 99mTc-complex at 20 h. Pinhole micro-SPECT images demonstrated that 99mTc-liposomes also have a superior intratumoral 99mTc-activity diffusion compared with unencapsulated 99mTc-complex. Higher intratumoral retention of 99mTc-liposomes accompanied by an improved intratumoral diffusion suggests that intratumorally administered liposomal drugs are potentially promising agents for solid tumor local therapy.

AB - Liposomes have recognized advantages as nano-particle drug carriers for tumor therapy. In this study, the pharmacokinetics and distribution of intratumorally administered liposomes were investigated as drug carriers for treating solid tumors via direct intratumoral administration. 99mTc-liposomes were administered intratumorally to nude rats bearing human head and neck squamous cell carcinoma xenografts. Planar gamma camera images were analyzed to evaluate the local retention of the intratumorally administered liposomes. Co-registered pinhole micro-single photon emission computed tomography (SPECT)/computed tomography (CT) images were acquired of the whole animal as well as the dissected tumors to determine intratumoral distribution of the 99mTc-liposomes. For 99mTc-liposomes, there was an initial retention of 47.4 ± 11.0% (n = 4) in tumors and surrounding tissues. At 20 h, 39.2 ± 10.6% (n = 4) of 99mTc-activity still remained in the tumor. In contrast, only 18.7 ± 3.3% (n = 3) of the intratumoral 99mTc-activity remained for unencapsulated 99mTc-complex at 20 h. Pinhole micro-SPECT images demonstrated that 99mTc-liposomes also have a superior intratumoral 99mTc-activity diffusion compared with unencapsulated 99mTc-complex. Higher intratumoral retention of 99mTc-liposomes accompanied by an improved intratumoral diffusion suggests that intratumorally administered liposomal drugs are potentially promising agents for solid tumor local therapy.

KW - Drug delivery

KW - Intratumoral administration

KW - Liposomes

KW - Micro-CT

KW - Micro-SPECT

KW - Nuclear imaging

UR - http://www.scopus.com/inward/record.url?scp=33646802287&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646802287&partnerID=8YFLogxK

U2 - 10.1016/j.ijpharm.2006.02.039

DO - 10.1016/j.ijpharm.2006.02.039

M3 - Article

C2 - 16580161

AN - SCOPUS:33646802287

VL - 316

SP - 162

EP - 169

JO - International Journal of Pharmaceutics

JF - International Journal of Pharmaceutics

SN - 0378-5173

IS - 1-2

ER -